These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 27014640)

  • 21. A review of the immunopathogenesis of Brucellosis.
    Amjadi O; Rafiei A; Mardani M; Zafari P; Zarifian A
    Infect Dis (Lond); 2019 May; 51(5):321-333. PubMed ID: 30773082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Neutrophils in Brucellosis.
    Moreno E; Barquero-Calvo E
    Microbiol Mol Biol Rev; 2020 Nov; 84(4):. PubMed ID: 33055283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptome analysis of macrophages during Brucella abortus infection clarifies the survival mechanisms of the bacteria.
    Pannetta M; Smal M; Ferravante C; Eletto D; Di Rosa D; Alexandrova E; Rizzo F; Voli A; Tosco A; Weisz A; Porta A
    Diagn Microbiol Infect Dis; 2024 Sep; 110(1):116401. PubMed ID: 38878343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-specific resistance in Brucella infection].
    Moreno-Lafont MC; López-Santiago R
    Rev Latinoam Microbiol; 1996; 38(3-4):207-17. PubMed ID: 10932711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity to brucellosis.
    Skendros P; Boura P
    Rev Sci Tech; 2013 Apr; 32(1):137-47. PubMed ID: 23837372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells.
    Gross A; Terraza A; Ouahrani-Bettache S; Liautard JP; Dornand J
    Infect Immun; 2000 Jan; 68(1):342-51. PubMed ID: 10603407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment.
    Fugier E; Pappas G; Gorvel JP
    Expert Rev Mol Med; 2007 Dec; 9(35):1-10. PubMed ID: 18088444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome.
    Adams LG
    Vet Microbiol; 2002 Dec; 90(1-4):553-61. PubMed ID: 12414171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type IV secretion system of Brucella spp. and its effectors.
    Ke Y; Wang Y; Li W; Chen Z
    Front Cell Infect Microbiol; 2015; 5():72. PubMed ID: 26528442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?
    Baldwin CL; Goenka R
    Crit Rev Immunol; 2006; 26(5):407-42. PubMed ID: 17341186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Response to Mucosal
    López-Santiago R; Sánchez-Argáez AB; De Alba-Núñez LG; Baltierra-Uribe SL; Moreno-Lafont MC
    Front Immunol; 2019; 10():1759. PubMed ID: 31481953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the Type IV Secretion System Effector VceA Promotes Autophagy and Inhibits Apoptosis in Brucella-Infected Human Trophoblast Cells.
    Zhang J; Li M; Li Z; Shi J; Zhang Y; Deng X; Liu L; Wang Z; Qi Y; Zhang H
    Curr Microbiol; 2019 Apr; 76(4):510-519. PubMed ID: 30805699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathogenesis of infection and immune response.
    Weston D
    Br J Nurs; 2010 Sep 9-22; 19(16):S4-11. PubMed ID: 20852457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brucella discriminates between mouse dendritic cell subsets upon in vitro infection.
    Papadopoulos A; Gagnaire A; Degos C; de Chastellier C; Gorvel JP
    Virulence; 2016; 7(1):33-44. PubMed ID: 26606688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions.
    Salcedo SP; Marchesini MI; Degos C; Terwagne M; Von Bargen K; Lepidi H; Herrmann CK; Santos Lacerda TL; Imbert PR; Pierre P; Alexopoulou L; Letesson JJ; Comerci DJ; Gorvel JP
    Front Cell Infect Microbiol; 2013; 3():28. PubMed ID: 23847770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector Proteins of Type IV Secretion System: Weapons of
    Zheng M; Lin R; Zhu J; Dong Q; Chen J; Jiang P; Zhang H; Liu J; Chen Z
    Curr Stem Cell Res Ther; 2024; 19(2):145-153. PubMed ID: 36809969
    [No Abstract]   [Full Text] [Related]  

  • 37. [MOLECULAR ASPECTS OF BRUCELLA PERSISTENCE].
    Kulakov Yu K
    Mol Gen Mikrobiol Virusol; 2016; 34(1):3-8. PubMed ID: 27183714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brucella: functional genomics and host-pathogen interactions.
    Rajashekara G; Eskra L; Mathison A; Petersen E; Yu Q; Harms J; Splitter G
    Anim Health Res Rev; 2006; 7(1-2):1-11. PubMed ID: 17389050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bacterial Second Messenger Cyclic di-GMP Regulates Brucella Pathogenesis and Leads to Altered Host Immune Response.
    Khan M; Harms JS; Marim FM; Armon L; Hall CL; Liu YP; Banai M; Oliveira SC; Splitter GA; Smith JA
    Infect Immun; 2016 Dec; 84(12):3458-3470. PubMed ID: 27672085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis and immune response in Brucella infection acquired by the respiratory route.
    Ferrero MC; Alonso Paiva IM; Muñoz González F; Baldi PC
    Microbes Infect; 2020 Oct; 22(9):407-415. PubMed ID: 32535086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.